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Abstract
Background: In previous analyses, we identified a region of chromosome 19 as harboring a susceptibility locus for
chronic otitis media with effusion and/or recurrent otitis media (COME/ROM). Our aim was to further localize the
linkage signal and ultimately identify the causative variant or variants. We followed up our previous linkage scan
with dense SNP genotyping across in a 5 Mb region. A total of 607 individuals from 139 families, including 159
affected sib pairs and 62 second-degree affected relative pairs, were genotyped at 1,091 SNPs. We carried out a
nonparametric linkage analysis, modeling marker-to-marker linkage disequilibrium.
Results: The maximum log of the odds (LOD) score increased to 3.75 (P = 1.6 × 10
-5) at position 63.4 Mb, with a
LOD-1 support interval between 61.6 Mb and 63.8 Mb, providing significant evidence of linkage between this
region and COME/ROM. The support interval contains over 90 known genes, including several genes involved in
the inflammasome protein complex, a key regulator of the innate immune response to harmful exogenous or
endogenous stimuli. Parametric linkage analysis suggests that for a sib of an affected individual, the recurrence risk
of COME/ROM due to this linkage region is twice the recurrence risk in the population. We examined potential
associations between the SNPs genotyped in this region and COME/ROM, however none provided evidence for
association.
Conclusion: This study has refined the 19q region of linkage with COME/ROM, and association results suggest that
the linkage signal may be due to rare variants.
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Background
Otitis media (OM), or inflammation of the middle ear,
represents a leading reason for physician visits by chil-
dren and a major component of the pediatric healthcare
burden [1]. A significant proportion of children who
suffer from acute OM go on to experience either
chronic otitis media with effusion (COME) or recurrent
otitis media (ROM). COME/ROM can result in perma-
nent hearing loss, tympanic membrane abnormalities,
other infections such as meningitis, parental days lost
from work, and other sequelae [2,3].
Genetic factors play an important role in COME/
ROM susceptibility. COME/ROM aggregates in families
[4-7], and first-degree relatives of COME/ROM patients
have higher rates of otitis media than would be expected
based on population rates [8]. Twin and triplet studies
confirm the strong familial component of COME and
ROM, with heritability estimates of 0.64-0.74 in mono-
zygotic twins and 0.20-0.53 in dizygotic twins [9-13].
To date, two linkage studies for COME/ROM have
been published but the loci identified in the two studies
did not overlap. The first genome-wide linkage scan,
conducted by our group [14], identified evidence of link-
age to chromosomal regions on 10q26 and 19q13, and
support for linkage on 3p conditional on linkage at 10q
and 19q. Casselbrant et al. identified linkage peaks on
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In order to localize the linkage signal on chromosome
19 and identify susceptibility genes for COME/ROM, we
have conducted fine mapping across this region, and
evaluated these SNPs for linkage and association.
Methods
Subjects
This study was conducted with Institutional Review
Board approval at the University of Minnesota, Wake
Forest University, and the University of Virginia, and
adhered to the tenets of the Declaration of Helsinki.
Subjects who had tympanostomy tube surgery for
COME/ROM (probands) and their families were
recruited for the study, which has been described pre-
viously [8,14,16]. An otolaryngologist performed an ear
examination to determine presence of OM sequelae
without knowledge of the subject’s prior OM history. In
addition, tympanometric testing was performed in sub-
jects at three frequencies (226, 630 or 710, and 1400
Hz) to detect abnormal middle ear mechanics, and hear-
ing was screened at 20dB for speech frequencies. The
current analyses included all subjects from the initial
linkage scan of Daly et al. ( [14], with the addition of six
new families rascertained and recruited using the same
criteria [14]. A total of 607 individuals from 139
families, including 159 affected sib pairs and 62 second-
degree affected relative pairs, were used in analyses.
SNP selection and genotyping
We selected 1,536 SNPs for genotyping, including 1,492
chromosome 19 SNPs chosen from a combination of
tagging, nonsynonymous and synonymous coding SNPs,
physical coverage, and putative copy number variation
(CNV) interrogation. Forty-four Ancestry Informative
Markers (AIMs) spaced across the genome were
included to verify major ethnic group membership and
to detect European stratification in the families. Geno-
typing was carried out by the Center for Inherited Dis-
ease Research (CIDR) using Illumina’s GoldenGate assay
[17].
Statistical analyses
After removal of SNPs on the basis of poor genotype
quality, missing data, excessive replicate and/or Mende-
lian errors [18-20], or monomorphic status, 1,091 SNPs
were available for analyses. Deviations from Hardy
Weinberg Equilibrium (HWE) in 223 unrelated indivi-
duals were determined using the exact test [18], and all
SNPs were in Hardy-Weinberg equilibrium (P > 0.0001).
Two monozygotic (MZ) twin pairs were detected and
incorporated in the analysis. The computer program
package Merlin [20] was used to identify and resolve
inconsistencies within families.
The Kong and Cox linear nonparametric linkage
(NPL) method [21] as implemented in Merlin was used
for the NPL linkage analysis. Marker-marker linkage dis-
equilibrium (LD) was modeled in the linkage analysis
using the maximum-likelihood clustered marker
approach [22] implemented in Merlin with thresholds of
r
2 >0 . 5a n dr
2 > 0.2. We also explored other strategies
to take into account the potential impact of LD on the
validity of our linkage findings. We analyzed a subset of
90 families (out of 139 families in total) in which all
affected individuals have complete parental data. This
subset of data is expected to be free of the LD effect on
linkage [22].
The Linkage and Association Modeling in Pedigrees
(LAMP) method [23] was used for the parametric link-
age analysis. In contrast to other parametric linkage
methods, the LAMP method does not require the speci-
fication of the genetic model of the disease, and para-
meters such as the penetrance of each genotype
(probability of affected status given genotype) and the
frequency of the disease susceptibility allele can be esti-
mated from the data.
In order to investigate whether the support for linkage
on chromosome 19q can be explained by a common
genetic variant in the region, we applied three family-
based association tests, the Transmission/Disequilibrium
Test (TDT) [24], the Generalized Disequilibrium Test
(GDT) [25], and the more powerful Quasi-Likelihood
Score test MQLS [26]. The TDT method examines the
allele transmission disparity from heterozygote parents
to their affected offspring. Although the TDT is viewed
as the standard of family-based association tests, the
presence of linkage without allelic association can result
in an inflated false positive rate [27]. The GDT method
generalizes the comparison between parent and off-
spring to all discordant relative pairs, including those
families with incomplete parental data that cannot be
handled in the standard TDT method. The GDT
method also allows the adjustment of linkage in the
association analysis. We included sex as a covariate and
incorporated the identical-by-descent (IBD) statistics in
the GDT analysis. The MQLS method also incorporates
association evidence across families and has been shown
to be more powerful in many settings than standard
methods. The prevalence of otitis media is specified at
0.1 in MQLS and only 137 Caucasian families (the
reported ethnicity has been verified with AIMs) are
included in the MQLS analysis. We also imputed the
HapMap [28] CEU SNPs to identify potential associated
variants that were not included in our SNP panel [29].
Results
The maximum LOD score of the NPL linkage analysis
was 3.75 (P = 1.6 × 10
-5) at 110.5 cM (corresponding to
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Page 2 of 663.4 Mb in physical distance), when the marker-marker
LD was modeled at either r
2 > 0.5 or r
2 >0 . 2 .T h i s
result supported significant evidence for linkage between
the 19q region and COME/ROM (Figure 1). The LOD-1
support interval (the interval in which the LOD score is
within 1 unit of its maximum, which is usually treated
as a confidence region [30]) for the identified linkage
was between 107.3 cM and 111.1 cM (61.6 Mb and 63.8
Mb in physical distance). When the marker-marker LD
was not modeled, the maximum LOD score was 4.41 at
109.4 cM. The large difference of the maximum LOD
scores between the two models (with LD modeled vs.
not modeled) reflects the inflation of linkage due to the
unaccounted marker-marker LD among the dense SNPs
[22].
When 90 families (65% of total number of families)
with complete parental data were included in the link-
age analysis, the maximum LOD score was 2.85. Note
the other 35% of data contains additional linkage evi-
dence that can be estimated as shown above [22]. Since
the marker-marker LD does not influence the linkage
analysis in 65% of the data even without modeling LD
in the analysis [22], and our result provides a projected
LOD score of 4.38 for the entire set of families for the
hypothetical case when all 138 families have complete
parental information, the identified linkage in the 19q
region is further supported.
The maximum LOD score based upon parametric
linkage analysis was 5.42 at 107.5 cM, corresponding to
P = 1.6 × 10
-5. For a sibling of an affected individual,
the recurrence risk of COME/ROM attributable to the
19q locus is twice as high as the recurrence risk in the
population.
No statistically significant (P < 0.0003) association
between any SNP and COME/ROM was identified (Fig-
ure 2). Using a Bonferroni correction, 1,091 SNPs
requires a nominal significance level of P < 4.6 × 10
-5.
Since the number of independent SNPs should be less
than 1,091 because of the LD between SNPs, we esti-
mated the number of independent SNPs by pruning
pairwise LD between SNPs. There are 216 SNPs that are
in approximate linkage disequilibrium with each other
Figure 1 LOD scores at 19q. The dotted line indicates a non-parametric linkage scan without modeling marker-marker LD. The dashed and
solid lines indicate non-parametric LOD scores with LD modeled at r
2 > 0.5 and r
2 > 0.2 respectively. The dot-dash line indicates the linkage
scan when only a subset of 90 families (out of 139 families in total) with complete parental data were included in the analysis.
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2 < 0.1), and a Bonferroni correction based on 216
SNPs gives a nominal significance level of P < 0.00023.
None of the observed associations reach either level of
significance.
The five strongest associations identified through the
TDT family-based association analyses (P value < 0.001)
all fall in the LOD-1 support interval. In contrast, none
of the family-based GDT or MQLS analyses yielded
Figure 2 P values of association from two association tests: A. TDT, B. GDT, C. MQLS. P values in -log10 scale are represented by circles. The
solid line indicates p values of non-parametric LOD scores with LD modeled at r
2 > 0.2.
Chen et al. BMC Medical Genetics 2011, 12:124
http://www.biomedcentral.com/1471-2350/12/124
Page 4 of 6significant evidence of association (P < 0.001). The
strongest association detected by TDT reflects the infla-
tion of the statistics due to linkage in the region, rather
than by association at a single variant [25]. Using GDT
analysis, the strongest association (P = 0.0024) falls out-
side of the LOD-1 support interval.
Rare variants in this region of 19q are much less
represented than common variants in our SNP panel.
Among all 1,091 SNPs, there are only 81 SNPs with a
minor allele frequency less than 5%. The lack of signifi-
cant association is consistent with evidence that linkage
in the 19q region is not due to common genetic
variants.
Discussion
We extended our previously reported linkage analysis on
chromosome 19q with dense SNP genotyping in the criti-
cal 5 Mb region. Analyses of these additional data con-
firmed significant evidence supporting linkage in this
region to COME/ROM, increasing the LOD score from
2.61 [14] to 3.75 at position 63.4 Mb. The SNP closest to
D19S254 (62.359 Mb), the marker with the maximum
LOD score of 2.61 in the original linkage scan [14], is
rs810859 (62.358 Mb), and the LOD score at this SNP is
3.38 (with LD r
2 > 0.2 modeled). The dense markers, as
well as a larger sample size, have therefore helped improve
the LOD score and localize the region of linkage. Addi-
tionally, parametric linkage analysis of our data suggests
that for a sibling of an affected individual, the recurrence
risk of COME/ROM that is due to this linkage region is
twice as high as the recurrence risk in the population. Our
analysis provides evidence that a COME/ROM susceptibil-
ity locus can be found within this region.
The LOD-1 support interval represents the telomeric
region of chromosome 19. This region is high in gene
content, containing over 90 known genes. Many of the
genes in this region are zinc finger and zinc finger-
related genes. Potential candidates for COME/ROM sus-
ceptibility include ZNF71, an endothelial zinc finger
gene induced by TNF-a [31], ZNF8, which represses
BMP and FGFß pathways important during develop-
ment {Jiao, 2002 #32}, and ZNF304,w h i c hh a sb e e n
found to activate lymphocytes [32]. Other candidate
genes in this region include members of the inflamma-
some protein complex, NLRP13, NLRP5 and NLRP8.
Inflammasomes are key regulators of the innate immune
response to harmful exogenous or endogenous stimuli
[33,34] Alpha-1-B glycoprotein (A1BG) is similar in
sequence to proteins in the immunoglobulin supergene
family, and has been associated with severe inflamma-
tion [35]. Chromatin modifying protein 2A (CHMP2A)
is part of the chromatin-modifying protein/charged mul-
tivesicular body protein (CHMP) involved in surface
receptor degradation and formation of endocytic bodies
[36]. Clearly, there are many genes within the linkage
peak region on chromosome 19 with biological func-
tions of potential relevance to COME/ROM susceptibil-
ity. The actions of multiple genes in this region, rather
than a single gene, on COME/ROM risk cannot be
excluded.
Conclusion
In summary, we confirmed linkage of COME/ROM to
chromosome 19q in a family based population with
dense genotyping of a previously identified 5 Mb region.
The lack of significant association with common var-
iants in this region suggests that the observed significant
linkage may be due to rare variants. Numerous studies
have provided evidence that rare variant are involved in
the etiology of complex traits (Liu and Leal, 2010).
Further examination of the 19q region in COME/ROM
susceptibility by next-generation sequencing of the
region may be required in order to detect rare variants
that may have novel and functionally significant effects.
These studies are currently underway to determine the
COME/ROM susceptibility gene in this region.
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